September 8, 2011 -- Shanghai Fosun Pharmaceutical (Group) will pay up to 1.4 billion RMB ($219 million) to acquire a 70% stake in Jinzhou Ahon Pharmaceutical Co., Ltd. A wholly-owned subsidiary, Shanghai Fosun Pharmaceutical Industry Development Co., Ltd., will be the acquirer. Shanghai Fosun said the acquisition will make its drug portfolio more competitive, especially in Ahon’s core strengths of the cardiovascular and central nervous system treatment sectors. More details....
Stock Symbol: (SHE: 600196)
